DACRYOSTENOSIS ACQUIRED side effect
What is DACRYOSTENOSIS ACQUIRED ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
DACRYOSTENOSIS ACQUIRED and Recently Reported Side Effects
DACRYOSTENOSIS ACQUIRED and 15 most Active Side Effect polls
DACRYOSTENOSIS ACQUIRED and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with DACRYOSTENOSIS ACQUIRED
COSOPT FORTEO HUMIRA KETEK LUCENTIS NATALIZUMAB PACLITAXEL PRENATAL REBIF RESTASIS SPIRIVA TOBRAMYCINPaclitaxel Side Effects Report #5678832-1
Consumer or non-health professional from UNITED STATES reported PACLITAXEL problem on Mar 13, 2008. Male patient, 66 years of age, was diagnosed with angiosarcoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dacryostenosis acquired, impaired healing, intraocular pressure increased, punctate keratitis, scar, . PACLITAXEL dosage: 175 MG/M2. Patient recovered.
Restasis Side Effects Report #5624835-2
RESTASIS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2008. Female patient, 57 years of age, was diagnosed with dry eye and was treated with RESTASIS. After drug was administered, patient experienced the following problems/side effects: dacryostenosis acquired, lacrimation increased, . RESTASIS dosage: unknown. During the same period patient was treated with VITAMIN CAP, SYNTHROID. Patient recovered.
Forteo Side Effects Report #5557898-3
Physician from FRANCE reported FORTEO problem on Dec 05, 2007. Female patient, weighting 123.5 lb, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: dacryostenosis acquired, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.
Forteo Side Effects Report #5528926-6
FORTEO problem was reported by a Consumer or non-health professional from FRANCE on Nov 15, 2007. Female patient, 77 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: dacryostenosis acquired, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.
Tobramycin Side Effects Report #5465195-X
Consumer or non-health professional from UNITED STATES reported TOBRAMYCIN SULPHATE problem on July 09, 2007. Male patient was diagnosed with conjunctivitis and was treated with TOBRAMYCIN SULPHATE. After drug was administered, patient experienced the following problems/side effects: dacryostenosis acquired, . TOBRAMYCIN SULPHATE dosage: unknown. Patient was hospitalized. Patient recovered.
Lucentis Side Effects Report #5713390-4
LUCENTIS problem was reported by a Consumer or non-health professional from SWITZERLAND on Apr 07, 2008. Female patient was treated with LUCENTIS. After drug was administered, patient experienced the following problems/side effects: dacryostenosis acquired, . LUCENTIS dosage: unknown. Patient recovered.
Rebif Side Effects Report #5593266-6
Health Professional from UNITED STATES reported REBIF problem on Jan 04, 2008. Female patient, 42 years of age, weighting 210.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: cataract, dacryostenosis acquired, iritis, rash maculo-papular, vitreous floaters, . REBIF dosage: unknown. During the same period patient was treated with PREDNISONE, WELLBUTRIN. Patient recovered.
Humira Side Effects Report #5560236-3
HUMIRA problem was reported by a Physician from UNITED STATES on Nov 01, 2007. Female patient, weighting 152.1 lb, was diagnosed with crohn's disease and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: crohn's disease, dacryostenosis acquired, eye disorder, eye infection bacterial, . HUMIRA dosage: unknown. During the same period patient was treated with WARFARIN, LANSOPRAZOLE. Patient recovered.
Natalizumab Side Effects Report #5414679-9
Health Professional from UNITED STATES reported NATALIZUMAB problem on July 28, 2007. Female patient, 56 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: corneal disorder, dacryostenosis acquired, dehydration, eye pain, headache, influenza, mouth breathing, multiple sclerosis relapse, nausea, . NATALIZUMAB dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
Paclitaxel Side Effects Report #5402059-1
PACLITAXEL problem was reported by a Health Professional from UNITED STATES on July 17, 2007. Male patient, 66 years of age, was diagnosed with angiosarcoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: cutis laxa, dacryostenosis acquired, ectropion, intraocular pressure increased, mucous membrane disorder, punctate keratitis, scar, . PACLITAXEL dosage: 175 MG/M2. Patient was hospitalized. Patient recovered.
Paclitaxel Side Effects Report #5402059-1
Health Professional from UNITED STATES reported PACLITAXEL problem on July 17, 2007. Male patient, 66 years of age, was diagnosed with angiosarcoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: cutis laxa, dacryostenosis acquired, ectropion, intraocular pressure increased, mucous membrane disorder, punctate keratitis, scar, . PACLITAXEL dosage: 175 MG/M2. Patient was hospitalized. Patient recovered.
Spiriva Side Effects Report #5349859-4
SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on June 01, 2007. Male patient, 65 years of age, was diagnosed with chronic obstructive pulmonary disease, diabetes mellitus, hypertension, blood cholesterol, angina pectoris, gastric polyps and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: constipation, dacryostenosis acquired, dry mouth, eye pain, headache, intraocular pressure increased, lung neoplasm, neoplasm prostate, renal neoplasm, . SPIRIVA dosage: unknown. During the same period patient was treated with AVANDAMET, DIOVAN HCT, FENOFIBRATE, ADVAIR DISKUS, NITROSTAT, WARFARIN, FIBERCON, CENTRUM SILVER. Patient recovered.
Paclitaxel Side Effects Report #5363385-8
Health Professional from UNITED STATES reported PACLITAXEL problem on June 18, 2007. Male patient, 66 years of age, was diagnosed with angiosarcoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: corneal staining, dacryostenosis acquired, ectropion, intraocular pressure increased, lacrimation increased, punctate keratitis, . PACLITAXEL dosage: unknown. Patient recovered.
Spiriva Side Effects Report #5327929-4
SPIRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on May 15, 2007. Male patient, 65 years of age, was diagnosed with chronic obstructive pulmonary disease, diabetes mellitus, hypertension, blood cholesterol, angina pectoris, gastric polyps and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: constipation, dacryostenosis acquired, dry mouth, eye pain, headache, intraocular pressure increased, lung neoplasm, neoplasm prostate, renal neoplasm, . SPIRIVA dosage: unknown. During the same period patient was treated with AVANDAMET, DIOVAN HCT, FENOFIBRATE, ADVAIR DISKUS, NITROSTAT, WARFARIN, FIBERCON, CENTRUM SILVER. Patient recovered.
Cosopt Side Effects Report #5507806-6
Physician from UNITED STATES reported COSOPT problem on Oct 26, 2007. Female patient, 81 years of age, was diagnosed with glaucoma and was treated with COSOPT. After drug was administered, patient experienced the following problems/side effects: arthritis, back pain, dacryostenosis acquired, eye discharge, eyelid margin crusting, glaucoma, musculoskeletal stiffness, rectal haemorrhage, thrombosis, . COSOPT dosage: unknown. During the same period patient was treated with XALATAN, ALPHAGAN, ASPIRIN, OMEGA. Patient recovered.
Natalizumab Side Effects Report #5394836-0
NATALIZUMAB problem was reported by a Health Professional from UNITED STATES on July 10, 2007. Female patient, 56 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: bacterial infection, corneal disorder, dacryostenosis acquired, dehydration, eye burns, influenza, parotitis, sinusitis, . NATALIZUMAB dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.
Natalizumab Side Effects Report #5394836-0
Health Professional from UNITED STATES reported NATALIZUMAB problem on July 10, 2007. Female patient, 56 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: bacterial infection, corneal disorder, dacryostenosis acquired, dehydration, eye burns, influenza, parotitis, sinusitis, . NATALIZUMAB dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.
Prenatal Side Effects Report #5322323-4
PRENATAL VITAMINS problem was reported by a Physician from on May 01, 2007. Female patient, weighting 3.50 lb, was diagnosed with obsessive-compulsive disorder and was treated with PRENATAL VITAMINS. After drug was administered, patient experienced the following problems/side effects: aorta hypoplasia, coarctation of the aorta, dacryostenosis acquired, foetal distress syndrome, placental insufficiency, premature baby, respiratory arrest, small for dates baby, . PRENATAL VITAMINS dosage: unknown. During the same period patient was treated with DIGOXIN, LASIX, PROZAC. Patient recovered.
Ketek Side Effects Report #5300456-6
Consumer or non-health professional from CANADA reported KETEK problem on Apr 11, 2007. Female patient, 26 years of age, was diagnosed with sinusitis, pharyngitis, pharyngolaryngeal pain and was treated with KETEK. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, blister, dacryostenosis acquired, erythema, lip swelling, madarosis, respiratory disorder, speech disorder, swelling face, . KETEK dosage: unknown. During the same period patient was treated with CEFZIL. Patient recovered.